
The different types of insulin are categorized according to how fast they start to work (onset) and how long they continue to work (duration). The types now available include rapid-, short-, intermediate-, and long-acting insulin.
Rapid-acting
| Generic Name | Brand Name |
|---|---|
| insulin aspart | NovoLog |
| insulin glulisine | Apidra |
| insulin lispro | Humalog |
Short-acting
| Generic Name | Brand Name |
|---|---|
| insulin regular | Humulin-R |
Intermediate-acting
| Generic Name | Brand Name |
|---|---|
| insulin NPH | Humulin-N |
Long-acting
| Generic Name | Brand Name |
|---|---|
| insulin detemir | Levemir |
| insulin glargine | Lantus |
There are premixed rapid- and intermediate-acting insulins available, including:
Injectable insulin is packaged in small glass vials (bottles) and cartridges that hold more than one dose and are sealed with rubber lids. The cartridges are used in pen-shaped devices called insulin pens.
Insulin usually is given as an injection into the tissues under the skin (subcutaneous). It can also be given through an insulin pump, an insulin pen, or jet injector, a device that sprays the medicine into the skin. Some insulins can be given through a vein (only in a hospital).
Research is ongoing to develop not only new forms of insulin but also insulin that can be taken in other ways, such as by mouth or nasal spray.
Insulin lets sugar (glucose) in the blood enter cells, where it is used for energy. Without insulin, the blood sugar level rises above what is safe for the body.
Your body uses insulin in different ways. Sometimes you need insulin to work quickly to reduce blood sugar. Your body also needs insulin on a regular basis to keep your blood sugar within a normal or near normal range.
Insulin is used to treat:
Insulin is effective in reducing blood sugar levels by helping sugar (glucose) enter the cells to be used for energy.
Results of the 10-year Diabetes Control and Complications Trial (DCCT) and the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study showed that people with type 1 diabetes who kept their blood sugar levels tightly within a normal or near-normal range (tightly controlled therapy) had fewer incidences of eye, kidney, and nerve damage from diabetes than people who were on standard therapy. Tightly controlled therapy also lowered the risk of heart attacks and deaths from heart disease.1
One study shows that insulin glargine (Lantus) is as effective as NPH insulin in controlling blood sugar in people with type 1 diabetes. Lantus causes fewer low blood sugar episodes than NPH.2
Results of the United Kingdom Prospective Diabetes Study (UKPDS) showed that insulin decreased the risk of diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy in people with type 2 diabetes.
The major side effect of insulin can be a dangerously low blood sugar level (severe hypoglycemia). A very low blood sugar level can develop within 10 to 15 minutes with rapid-acting insulins.
Insulin can contribute to weight gain, especially in people with type 2 diabetes who already are overweight.
Other possible side effects of long-term insulin use include the loss of fatty tissue (lipodystrophy) where the insulin is injected and, in rare cases, allergic reactions that include swelling, or edema.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
People with type 1 diabetes who tightly control their blood sugar levels using either multiple daily injections or the insulin pump have lower hemoglobin A1c levels and may reduce their risk for developing small blood vessel complications (eye and kidney disease) compared to people who take one or two injections every day.3
The insulin pump provides a way to give insulin with less frequent injections and is as effective as multiple daily injections at keeping blood sugar levels within a target range.
The long-acting insulin glargine (Lantus) may help prevent some people from having frequent nighttime low blood sugar levels. It may also be helpful for people who have had difficulty keeping their blood sugar levels within their target range with intermediate-acting insulin.
Giving short-acting insulin at the evening meal and NPH at bedtime instead of giving them together at the evening meal may reduce the risk of nocturnal hypoglycemia and hypoglycemia unawareness.4
Some factors that affect how fast and how well an insulin dose works are:
The long-acting insulin glargine (Lantus):
Insulin may be given as a single nighttime dose or as several smaller doses throughout the day.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353(25): 2643–2653.
- Ratner RE, et al. (2000). Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care, 23(5): 639–643.
- Cheng AYY, Zinman B (2001). Insulin for treating type 1 and type 2 diabetes. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 323–343. Hamilton, ON: BC Decker.
- Fanelli CG, et al. (2002). Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. Annals of Internal Medicine, 136(7): 504–514.
Last Revised: October 3, 2008
Author: Healthwise Staff
Medical Review: Caroline S. Rhoads, MD - Internal Medicine & Matthew I. Kim, MD - Endocrinology
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions
To learn more visit Healthwise.org
© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
